Vizora日本語

Kissei PharmaceuticalKISSEI PHARMACEUTICAL CO.,LTD.4547東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Kissei Pharmaceutical FY ending Mar 2022 results

About 83% of Kissei Pharmaceutical's sales come from Pharmaceutical products, with Information Service and Construction contracting making up much of the rest.

It lost about ¥2 for every ¥100 of sales at the operating level.

Revenue changed -5.3% from the prior year, operating profit -193.2%.

Revenue and profit pattern

Turned to a loss

What changed from last year

FY ending Mar 2021 → FY ending Mar 2022

Revenue
-5.3%¥69B → ¥65.4B
Gross profit
-4.5%¥32.7B → ¥31.2B
Operating income
-193.2%¥1.5B → -¥1.4B
Net income attributable to owners
+144.5%¥5.29B → ¥12.9B
Operating cash flow
Back to profit-¥2.54B → ¥1.53B
Free cash flow
Loss-¥4.03B → -¥386M

Where the money goes

FY ending Mar 2021 → FY ending Mar 2022

Where ¥100 of sales goes

For every ¥100 Kissei Pharmaceutical sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥52
SG&A
¥50
Operating loss
¥2
Net profit kept
¥20

Annual margin trends

Gross margin47.8%
FY ending Mar 2020: 55.2%55.2%FY ending Mar 2021: 47.4%47.4%FY ending Mar 2022: 47.8%47.8%FY20FY21FY22
Operating margin-2.1%
FY ending Mar 2020: 2.9%2.9%FY ending Mar 2021: 2.2%2.2%FY ending Mar 2022: -2.1%-2.1%FY20FY21FY22
Net margin19.8%
FY ending Mar 2020: 4.5%4.5%FY ending Mar 2021: 7.7%7.7%FY ending Mar 2022: 19.8%19.8%FY20FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2022

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第81期(2025/04/01－2026/03/31)

    ID S100YFN32026-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第80期(2024/04/01－2025/03/31)

    ID S100W31F2025-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第79期(2023/04/01－2024/03/31)

    ID S100TRIA2024-06-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第78期(2022/04/01－2023/03/31)

    ID S100R0YK2023-06-22Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第77期(令和3年4月1日－令和4年3月31日)

    ID S100OOE82022-07-06Open

  • EDINET (FSA Japan)

    有価証券報告書－第76期(令和2年4月1日－令和3年3月31日)

    ID S100LO0H2021-06-24Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image